Regenxbio (RGNX) Depreciation & Amortization (CF) (2015 - 2025)

Regenxbio's Depreciation & Amortization (CF) history runs 11 years deep, the most recent figure standing at $3.9 million for Q4 2025.

• In Q4 2025, Depreciation & Amortization (CF) fell 3.83% year-over-year to $3.9 million; the TTM figure through Dec 2025 stood at $15.6 million (down 3.7% YoY), while the FY2025 annual figure was $15.6 million, down 3.7% from the prior year.
• Depreciation & Amortization (CF) was $3.9 million for Q4 2025 at Regenxbio, roughly flat from $3.9 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $4.4 million in Q2 2023 to a low of $1.9 million in Q1 2021.
• Historically, Depreciation & Amortization (CF) has averaged $3.6 million across 5 years, with a median of $3.9 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Depreciation & Amortization (CF) soared 67.8% in 2023, then dropped 9.4% in 2024.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $2.6 million in 2021, then soared by 55.83% to $4.1 million in 2022, then increased by 4.81% to $4.3 million in 2023, then decreased by 6.77% to $4.0 million in 2024, then decreased by 3.83% to $3.9 million in 2025.
• The last three Depreciation & Amortization (CF) figures came in at $3.9 million (Q4 2025), $3.9 million (Q3 2025), and $3.9 million (Q2 2025), per Business Quant data.